2002
DOI: 10.1046/j.1365-2141.2002.03334.x
|View full text |Cite
|
Sign up to set email alerts
|

An estimate of the current risk of transmitting blood‐borne infections through blood transfusion in Italy

Abstract: Summary. We conducted a retrospective cohort study to estimate the incidence of major blood-borne agents among Italian blood donors and calculated the risk of infection among blood recipients using the Ôincidence/window period modelÕ. The study was conducted among 46 180 blood donors enrolled in six blood centres between 1994 and 1999. During follow-up, seven new infections were confirmed: three donors seroconverted for anti-human immunodeficiency virus (HIV); two for anti-hepatitis C virus (HCV); and two show… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
16
0

Year Published

2004
2004
2017
2017

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 46 publications
(16 citation statements)
references
References 28 publications
0
16
0
Order By: Relevance
“…4 Whether HBsAg-negative/anti-HBc-positive units can transmit HBV infection to recipients is debated. [13][14][15][16][17][25][26][27] The low viremic content and often the concomitant presence of neutralizing anti-HBs antibodies has led several authors to conclude that blood from anti-HBc/anti-HBs-positive donors is safe; the English experience seems reassuring as no case of hepatitis B transmission was related to transfusion in a survey of 20000 blood units controlled only for HBsAg.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…4 Whether HBsAg-negative/anti-HBc-positive units can transmit HBV infection to recipients is debated. [13][14][15][16][17][25][26][27] The low viremic content and often the concomitant presence of neutralizing anti-HBs antibodies has led several authors to conclude that blood from anti-HBc/anti-HBs-positive donors is safe; the English experience seems reassuring as no case of hepatitis B transmission was related to transfusion in a survey of 20000 blood units controlled only for HBsAg.…”
Section: Discussionmentioning
confidence: 99%
“…3 In a recent evaluation of the impact of the seronegative window phase on the residual risk of transmitting the three infections through blood transfusion in Italy, this was estimated to be 15.78 units per million for HBV compared to 2.45 and 4.45 units per million for HIV and HCV, respectively. 4 In the last 2 years, the risks of HCV and HIV transmission were further reduced to 0.5 and 1.1 units per million transfusions by the introduction of nucleic acid amplification technology (NAT) testing. 5 After the implementation of HBsAg screening in the 1970s, there have been no further measures in Italy to decrease the residual risk of HBV transmission, other than improving the sensitivity of the HBsAg assay.…”
mentioning
confidence: 99%
“…In the past, the selection of blood donor was considered the most important factor in reducing infections through blood transfusion. With the introduction of serologic test in blood banks, there was an enormous decrease in the most commonly encountered transmitted infectious blood diseases through blood [5]. These infections are blood-borne bacteria, parasites or viruses depending on their etiologic agents.…”
Section: Introductionmentioning
confidence: 99%
“…The management of central venous catheters was suspected to be the probable route of transmission. In conclusion, the MST model, supported by an exhaustive clinical-epidemiological investigation, appears to be a useful tool in tracing the history of transmission in outbreaks of HCV infection.Since the introduction of blood donor screening through antibody testing, the risk of acquiring infection with hepatitis C virus (HCV) through the transfusion of blood or blood products has dramatically decreased in industrialized countries (8,28,34). Nonetheless, the nosocomial transmission of HCV continues to occur (21).…”
mentioning
confidence: 99%
“…Since the introduction of blood donor screening through antibody testing, the risk of acquiring infection with hepatitis C virus (HCV) through the transfusion of blood or blood products has dramatically decreased in industrialized countries (8,28,34). Nonetheless, the nosocomial transmission of HCV continues to occur (21).…”
mentioning
confidence: 99%